- This event has passed.
Grand Rounds July 20: Developing Technology-Derived Novel Endpoints for use in Clinical Trials: Recommendations and Case Examples from the Clinical Trials Transformation Initiative
July 20, 2018 @ 1:00 pm - 2:00 pm
Will Herrington, MA, MBBS, MD, MRCP
MRC-Kidney Research UK Professor and
David Kerr Clinician Scientist
Nuffield Department of Population Health, University of Oxford
Rob DiCicco, PharmD
TransCelerate BioPharma Inc.
Jen Goldsack, MChem, MA, MBA, OLY
Senior Project Manager
Clinical Trials Transformation Initiative
Topic: Developing Technology-Derived Novel Endpoints for use in Clinical Trials: Recommendations and Case Examples from the Clinical Trials Transformation Initiative
Date: Friday, July 20, 2018, 1:00-2:00 p.m. ET
Meeting Info: To check whether you have the appropriate players installed for UCF (Universal Communications Format) rich media files, go to https://dukemed.webex.com/dukemed/systemdiagnosis.php.
To join the online meeting:
Go to https://dukemed.webex.com/dukemed/j.php?MTID=m1a4a0665a615ae0382440edecedbdd33
You must log in to the URL first.
Click ‘Audio Conference’
Choose ‘I will call in’, select the Toll Free number.
Dial in using the information from the dialog box that appears.
Be certain to use the Access Code AND the Attendee ID.
If the URL above does not work, go to dukemed.webex.com and enter:
Meeting Number: 739 348 059
Meeting Password: 1234
For Audio ONLY:
Call-in toll-free number (US/Canada): 1-855-244-8681
Access code: 739 348 059